ORMP
Oramed Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$3.41
+0.17 (+5.25%)
Open$3.28
Previous Close$3.24
Day High$3.41
Day Low$3.22
52W High$9.06
52W Low$6.19
Volume—
Avg Volume134.6K
Market Cap135.73M
P/E Ratio21.16
EPS$0.34
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+180.1% upside
Current
$3.41
$3.41
Target
$9.55
$9.55
$5.95
$9.55 avg
$10.69
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 32.69M | 32.28M | 32.90M |
| Net Income | 6.94M | 5.51M | 7.09M |
| Profit Margin | 21.2% | 17.1% | 21.6% |
| EBITDA | 9.65M | 8.62M | 9.08M |
| Free Cash Flow | 3.16M | 3.23M | 4.24M |
| Rev Growth | +22.5% | +15.3% | -1.3% |
| Debt/Equity | 0.15 | 0.19 | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |